It Is Now Time to Focus on Risk Before Age 40-Reference-Cited by-同舟云学术

It Is Now Time to Focus on Risk Before Age 40

Published:2019-07 Issue:3 Volume:74 Page:342-345
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Gidding Samuel S.,Robinson Jennifer

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference15 articles.

1. A diagnosis of the metabolic syndrome in youth that resolves by adult life is associated with a normalization of high carotid intima-media thickness and type 2 diabetes mellitus risk: the Bogalusa Heart and Cardiovascular Risk in Young Finns studies;Magnussen;J Am Coll Cardiol,2012

2. General cardiovascular risk profile for use in primary care: the Framingham Heart Study;D'Agostino;Circulation,2008

3. Can antihypertensive treatment restore the risk of cardiovascular disease to ideal levels?: the Coronary Artery Risk Development in Young Adults (CARDIA) Study and the Multi-Ethnic Study of Atherosclerosis (MESA);Liu;J Am Heart Assoc,2015

4. Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment;Wiegman;Eur Heart J,2015

5. Associations of blood pressure and cholesterol levels during young adulthood with later cardiovascular events;Zhang;J Am Coll Cardiol,2019

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rethinking Cholesterol Screening and Management in Young Adults;Journal of the American College of Cardiology;2024-09

2. Overcoming the real and imagined barriers to cholesterol screening in pediatrics;Journal of Clinical Lipidology;2024-05

3. When to treat hypercholesterolaemia;Medicina Clínica (English Edition);2024-03

4. Advanced waveform analysis of the photoplethysmogram signal using complementary signal processing techniques for the extraction of biomarkers of cardiovascular function;JRSM Cardiovascular Disease;2024-01

5. New-onset age of metabolic-associated fatty liver disease and incident cardiovascular diseases: Findings from prospective cohort;The Innovation Medicine;2024